Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial

Weiqing Wang,Luis Nevarez,Ekaterina Filippova,Ki Ho Song,Bei Tao,Liqun Gu,Feng Wang,Pengfei Li,Jun Yang

Efficacy and safety of once‐weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52‐week open‐label, randomized phase III trial

2019

Weiqing Wang
Luis Nevarez
Ekaterina Filippova
Ki Ho Song
Bei Tao
Liqun Gu
Feng Wang
Pengfei Li
Jun Yang

Aim To compare the efficacy and safety of once‐weekly dulaglutide with that of insulin glargine in combination with metformin and/or a sulphonylurea in mainly Asian patients with type 2 diabetes mellitus (T2DM).

Keywords:

Endocrinology
Dulaglutide
Metformin
Type 2 diabetes
Insulin glargine
Type 2 Diabetes Mellitus
GLP-1 Analogue
Diabetes mellitus
Medicine
Internal medicine
Nausea
Population
Gastroenterology
Weight loss

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations